Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Jilemnice

3 clinical trials in Jilemnice, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Jilemnice at a glance
3
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

3 trials in Jilemnice

Open in trial search
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Chronic kidney disease+1

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Jilemnice

What the registry says about research in the country

01 Nephrology & Cardiovascular Research

Groundbreaking research focusing on the intersection of chronic kidney disease (CKD) and hypertension, evaluating innovative combination therapies to improve patient outcomes.

  • Kidney Function Assessment
  • Blood Pressure Management
  • Disease Progression Prevention

These trials investigate the effectiveness of combination treatments in slowing kidney disease progression while managing cardiovascular complications in adult patients.

02 Treatment Efficacy Studies

Clinical investigations comparing combination therapy approaches to standard treatments, focusing on measuring kidney function and cardiovascular outcomes in patients with complex conditions.

  • Therapeutic Comparisons
  • Safety Assessments
  • Clinical Outcomes Analysis

Research aims to establish superior treatment protocols for patients dealing with both kidney disease and high blood pressure.

03 Disease Management Research

Studies examining long-term outcomes in patients with dual diagnoses, focusing on kidney function preservation and cardiovascular risk reduction.

  • Disease Progression Monitoring
  • Kidney Function Preservation
  • Cardiovascular Protection

The research evaluates comprehensive treatment strategies to address both renal and cardiovascular aspects of disease management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.